These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods. Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines. Kamata S; Hashiyama R; Hana-Ika H; Ohkubo I; Saito R; Honda A; Anan Y; Akahoshi N; Noguchi K; Kanda Y; Ishii I Toxicol In Vitro; 2020 Dec; 69():104999. PubMed ID: 32949729 [TBL] [Abstract][Full Text] [Related]
9. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664 [TBL] [Abstract][Full Text] [Related]
10. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity. Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128 [No Abstract] [Full Text] [Related]
12. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity. Stern M; Gierse A; Tan S; Bicker G Arch Toxicol; 2014 Jan; 88(1):127-36. PubMed ID: 23917397 [TBL] [Abstract][Full Text] [Related]
13. microRNA Profiling as Tool for Developmental Neurotoxicity Testing (DNT). Smirnova L; Seiler AEM; Luch A Curr Protoc Toxicol; 2015 May; 64():20.9.1-20.9.22. PubMed ID: 26344224 [TBL] [Abstract][Full Text] [Related]
14. Developmental neurotoxicity of different pesticides in PC-12 cells in vitro. Christen V; Rusconi M; Crettaz P; Fent K Toxicol Appl Pharmacol; 2017 Jun; 325():25-36. PubMed ID: 28385489 [TBL] [Abstract][Full Text] [Related]
15. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing. Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830 [TBL] [Abstract][Full Text] [Related]
16. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment. Harrill JA; Freudenrich T; Wallace K; Ball K; Shafer TJ; Mundy WR Toxicol Appl Pharmacol; 2018 Sep; 354():24-39. PubMed ID: 29626487 [TBL] [Abstract][Full Text] [Related]
17. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity. Li J; Settivari R; LeBaron MJ; Marty MS Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249 [TBL] [Abstract][Full Text] [Related]
18. Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity. Ryan KR; Sirenko O; Parham F; Hsieh JH; Cromwell EF; Tice RR; Behl M Neurotoxicology; 2016 Mar; 53():271-281. PubMed ID: 26854185 [TBL] [Abstract][Full Text] [Related]
19. Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing. Cervetto C; Pistollato F; Amato S; Mendoza-de Gyves E; Bal-Price A; Maura G; Marcoli M Reprod Toxicol; 2023 Apr; 117():108358. PubMed ID: 36863571 [TBL] [Abstract][Full Text] [Related]
20. Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity. Chesnut M; Hartung T; Hogberg H; Pamies D Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]